로딩 중…
StockDiggingStockDigging

West Pharmaceutical Services, Inc.

WST· NYSE
$328.03+1.37%
2026-06-18

Price Chart

West Pharmaceutical Services, Inc.+50.89%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$23.17B
Revenue$3.22B
Net Income$543M
Total Assets$4.11B
Net Assets$2.99B
Employees10,800
Value
P/E42.70x
P/B7.75x
PEG0.78x
P/S7.20x
EV/EBITDA28.75x
FCF Yield1.98%
Profitability
ROE18.15%
ROA13.21%
Op. Margin20.67%
Revenue Growth21.01%
Earnings Growth54.57%
Financial Health
Debt Ratio37.43%
Total Debt$316M
FCF$458M
Cash$521M
Current Ratio2.71x
Net Debt/EBITDA-0.26x
Dividend
Div. Yield0.27%
Div. Growth4.56%
Performance
1Y Return50.89%
1M Return7.93%
From 52W High-2.61%
1Y MDD-24.70%
Trading
Volume563,349 shares
Trading Value$184M
Per Share
EPS$6.83
BPS$43.93

Company Info

CEO Mr. Eric M. Green
Employees 10,800
HQ Exton, United States

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.